ENTG · Entegris, Inc. — research history
Complete research history. Every dossier, draft, kill, publish, and lesson the system has produced on ENTG. Public so users can audit, AI can re-reference. Live price refreshes every 60s.
About ENTG · Entegris, Inc.
Entegris, Inc. provides advanced materials and process solutions for the semiconductor and other high-technology industries in North America, Taiwan, South Korea, Japan, China, Europe, and Southeast Asia. It operates in two segments, Materials Solutions (MS) and Advanced Purity Solutions (APS). The MS segment provides materials-based solutions, such as chemical vapor and atomic layer deposition materials, chemical mechanical planarization slurries and pads, ion implantation specialty gases, formulated etch and clean materials, and other specialty materials. The APS segment offers filtration, purification, and contamination-control solutions for the semiconductor manufacturing processes, semiconductor ecosystem, and other high-technology industries. The company's customers include logic and memory semiconductor device manufacturers, semiconductor equipment makers, gas and chemical manufacturing companies, and wafer grower companies; and outsourced semiconductor assembly and test facilities, flat panel display equipment makers, and manufacturers of hard disk drive components and devices. It serves manufacturers and suppliers in the solar and life science industries, electrical discharge machining customers, glass manufacturers, aerospace manufacturers, and manufacturers of biomedical implantation devices. Entegris, Inc. was founded in 1966 and is headquartered in Billerica, Massachusetts.
Live Quote
BUY (score +7) · 12-1 mom 60.8% · RSI 59.7 · above_both · -8.6% from high
Targets blend Wall Street consensus (10 analysts: low $115.00 / mean $160.60 / high $205.00) with chart-derived floors and ceilings.
1-Year Chart · RSI · MACD
Research Timeline
Newest first. Each entry shows what stage produced it, the verdict/decision, and the reasoning.
recent analyst:skip 78.9h ago < cooldown 168h, no material change
The stock is fully valued at a 38.7x forward P/E after a 137% YTD run, with no insider buying and material insider selling. Anti-signals (concentration, dilution) and stretched technicals leave no margin of safety for either a long or income structure.
Entegris is a $27B market cap semiconductor materials supplier operating two segments: Materials Solutions (deposition materials, CMP slurries/pads, etch chemicals) and Advanced Purity Solutions (filtration, contamination control). The stock has run +137% YTD to an all-time high of $178.77 — driven by AI-driven advanced packaging demand, molybdenum integration at advanced nodes, and EUV patent resolution with JSR/Inpria in May 2026. The options flow shows three OTM call whale blocks (180/200/220 strikes on Aug-21 expiry) with net +$2M directional bias, corroborated by strong Q1 EPS beat (+15.4% surprise). However, the stock is fully-valued at forward P/E ~38.7x versus sector median ~30-35x, and a director sold ~$513K in open-market shares on June 3rd (near current prices), which qualifies as an anti-signal. No CEO/CFO open-market purchases exist; all recent Form 4 buys were RSU vests or stock plan transactions. The Q2 earnings catalyst is July 30th, 2026 — 40 days away from spot.
Rich valuation (32.6x Fwd P/E, ~30x EV/EBITDA) leaves no margin of safety, and heavy insider selling (~$48.6M) negates smart-money support. While IV is elevated (~73%), the lack of mispricing and presence of concentration/dilution anti-signals make this dossier unsuitable for publication.
Entg has been on a strong run (+51% YTD, +70% 1yr) driven by AI-driven node migration and advanced chip contamination-control demand. The investigation trigger was flagged as '2 Form 4 filings in last 14 days — 1 real trade,' but after reading all relevant filings, the insider activity is predominantly routine: director RSU grants (Azita Saleki-Gerhardt, Yvette Kanouff on May 6), option exercises+10b5-1 sales by executives (Bertrand Loy April 17 ~$47M gross, Clint Haris May 27 ~$1.02M gross), and one director sale (James Lederer June 3). NO open-market buys were detected. The EUV cross-licensing agreement with JSR/Inpria (May 26) resolves a patent dispute but is not an earnings-level catalyst. Valuation is rich: forward P/E of 32.6 and EV/EBITDA ~30x against semiconductor equipment peers at 20-25x. Q1 EPS beat was strong (+15% vs estimate), but the stock has already re-rated significantly on AI-semiconductor optimism with limited room for further multiple expansion.
Entegris triggered on Form 4 cluster activity, but after reading all relevant filings, the pattern reflects routine option exercises and pre-scheduled 10b5-1 sales — not genuine open-market insider conviction buys. The stock has had a spectacular run (YTD +48%), is near all-time highs at $125, and trades at a demanding forward P/E of ~27x with elevated EV/EBITDA of ~25x. Q2 results are July 30 with recent beat history, but the valuation appears broadly fair-to-slightly-rich relative to semiconductor materials peers. The bearish put skew in options flow (6:1 put/call ratio) reflects macro hedging rather than an informed directional thesis. No material edge found.
The dossier flags customer concentration and dilution as anti-signals, shows zero insider buying, and the stock trades at a premium 30x forward P/E after a 70% run-up with no identifiable mispricing or margin of safety. While elevated IV (~70%) supports income structures, the lack of quality metrics and clear catalysts fails to clear the publication threshold.
The investigation reveals that the Form 4 cluster trigger (6 filings in 14 days) was almost entirely pre-scheduled option exercises and 10b5-1 sales by insiders — not open-market purchases. Zero true insider buys were found among recent filings; all executives exercised vested options at $98.11 or lower and immediately sold pursuant to pre-established trading plans. This fundamentally weakens the smart-money signal that triggered investigation. The business itself is operationally healthy — Q1 2026 EPS of $0.86 beat consensus by 15.4% on strong AI-driven advanced-node demand, gross margins expanded, new CFO with GlobalFoundries/Marvell pedigree appointed effective May 18, and an EUV cross-licensing agreement with JSR/Inpria adds strategic depth. However, the stock is up ~70% over one year and trades at forward P/E of 30x vs a semiconductor-materials sector that has compressed — making meaningful upside from current levels dependent on continued AI capex cycles rather than any identifiable mispricing. The verdict is range_bound_or_income: the fundamentals are solid but valuation leaves little room for error, and elevated IV (~70%) makes covered-call strategies attractive.
Material insider selling ($6.37M), stretched valuation trading at a premium to sector peers, poor quality metrics (ROIC 3.7%, 5.8x net debt/EBITDA), and active dilution/concentration anti-signals negate any income or structural opportunity. The market has already front-run the AI recovery narrative.
Entegris is a semiconductor materials and process solutions company that has surged 62% YTD on AI-driven contamination-control demand narrative, reaching $159 (52w high in April) before pulling back ~16%. Q1 FY26 delivered +15.4% EPS beat ($0.86 vs $0.75 estimate) driven by advanced logic/memory consumables; management guided Q2 to ~$830M in-line with consensus. The stock now sits at forward P/E 28.8x and EV/EBITDA 26.8x — premium-to-sector on weak technicals (below MA20, RSI neutral zone, bearish MACD cross 11 bars ago). No insider open-market purchases were found in the past 90 days; CEO Bertrand Loy executed a pre-planned Rule 10b5-1 sell of options exercise proceeds only. CFO transition (outgoing Linda LaGorga → interim Michael Sauer → incoming Sukhi Nagesh from GlobalFoundries/Marvell) creates mild execution risk ahead of July 30 earnings. ATM IV is 62-66%, making covered-call and strangle structures attractive at this level.
{"symbol":"ENTG","company":"Entegris, Inc.","investigation_summary":"ENTG is a high-quality semiconductor materials and purity-control supplier riding an AI buildout tailwind. The company reported a strong Q1 2026 beat (+15.4% EPS surprise, +5% revenue growth) with accelerating demand in both segments (APS +7%, MS +3%). However, the stock has nearly doubled over one year ($68.80 low → $159.15 high
{"symbol":"ENTG","company":"Entegris, Inc.","investigation_summary":"Entegris reported a strong Q1 FY2026 beat (+15.4% EPS surprise) and appointed a new CFO (Sukhi Nagesh from GlobalFoundries/Marvell) in late April 2026. A May 6 governance amendment eliminated supermajority voting requirements — a positive but marginal corporate structure improvement. The stock has had an extraordinary run (+82% Y